AzTrials
AzTrials

Spasticity, MuscleNCT04266964

Validity and Reliability Study of the Muscle Excitability Scale in Spinal Cord Injury Patients

An observational study of Spasticity, Muscle and Spinal Cord Injuries, run by University Hospital, Motol at 2 sites in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to verify validity and reliability of the Muscle excitability scale (MES), which has been developed to access muscle susceptibility to spasms and/or clones as part of spastic motor behavior in spinal cord injured patients. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Spasticity, Muscle, Spinal Cord Injuries
What is being tested?
Manual examination
Type of treatment
Surgery or procedure
How many people
50 participants
Where
2 sitesCzechia
Study dates
2 Jan 2020to 25 Feb 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Spasticity in spinal cord injury

Who may be able to join

  • Spasticity in Spinal Cord Injury

Who cannot join

  • Parallel brain injury
  • Cognitive deficit affecting cooperation
  • Acute infection or other sudden complication
  • Recent change of antispastic medication

Trial locations and contacts

2 sites in 1 country.

Czechia2 sites
  • Department of Rehabilitation and Sports Medicine, University Hospital Motol

    Prague, 150 06

  • Paraple Center - rehab center for SCI people

    Prague, 150 06

Other trials in Czechia

About this study

Official title: Muscle Excitability Scale for Assessment of Spastic Reflexes in Spinal Cord Injury. Part II: Validity and Reliability Study

The aim of the study is to verify validity and reliability of the Muscle excitability scale (MES), which has been developed to access muscle susceptibility to spasms and/or clones as part of spastic motor behavior in spinal cord injured patients.

Read the detailed description

The muscle excitability scale (MES) is intended for patients after spinal cord injury. The objective is to evaluate a motor response (muscle spasms or clones) to a sensory or motor stimulus. A sensory stimulus is created by thumb and pointfinger compression of cutaneous tissue on the inside part of the middle thigh and calf. A motor stimulus is created by passive movement of the lower limb to flexion and extension. The MES grades from 0 to 4 reflect the muscle spastic or clonic tendency and the extent of this motor response (from isolated to generalized). Two investigators will examine a spastic motor behavior in 50 chronic SCI subjects using MES, Modificated Ashworth Scale (MAS) and Penn Spasms Frequency Scale (PSFS) to verify the validity and reliability of the MES.

Being tested
Manual examination
Keywords
Spasticity, Spinal cord injury, Validity, Reliability
Medical subject headings
Muscle Spasticity, Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manual examinationProcedure or surgery

    With the patient in a supine position, squeeze the skinfold between your thumb and pointfinger on the inner aspect of the middle third of the thigh and on the inner aspect of the middle third of the calf.

    Place your hand under the proximal calf and the heel and move the leg into maximum flexion at the hip and knee joints. After the response, if any, is completed, move the limb back into full extension. Each of these movements lasts for one second.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle Excitability Scale

    Scoring from 0 to 4; 0 = no motor response (muscle spasm or clonus) to a tactile stimulus or passive movement; 4 = generalized motor response to both a tactile stimulus and passive movement

    Measured: through study completion, an average of 1 year

  2. Modified Ashworth Scale

    Scoring from 0 to 4; 0 = no increase in muscle tone; 4 = affected part(s) rigid in flexion or extension

    Measured: through study completion, an average of 1 year

  3. Penn Spasm Frequency Scale

    Scoring 0 to 4; 0 = no spasms; 4 = spasms occurring more than 10 times per hour

    Measured: through study completion, an average of 1 year

Secondary outcomes (1)
  1. Calculation of validity and reliability index of Muscle Excitability Scale

    To determine validity, inter-rater and intra-rater reliability of the Muscle Excitability Scale

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2020
  2. Study start2 Jan 2020
  3. Primary completion31 Jan 2023
  4. Study completion25 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04266964
Sponsor's protocol ID
SCI_MES_2019
Status last verified
Mar 2023
First submitted
5 Feb 2020
Last updated
14 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Kriz J, Hlinkova Z. Muscle excitability scale - a novel tool for evaluation of spastic motor behaviors in spinal cord injury patients. In: Proceedings from the 55th ISCoS Annual Scientific Meeting; September 14-16, 2016; Vienna, Austria. Abstract 186.

Questions about this trial

What is this clinical trial studying?

An observational study of Spasticity, Muscle and Spinal Cord Injuries, run by University Hospital, Motol at 2 sites in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle Excitability Scale (time frame: through study completion, an average of 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04266964, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in